![Stacey Liekweg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Stacey Liekweg has held positions as President & Director at Immunovalent Therapeutics, Inc. and Chief Operating Officer at Caelivascular, Inc.
Aktive Positionen von Stacey Liekweg
Unternehmen | Position | Beginn |
---|---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Präsident | - |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Health Technology |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Health Technology |